Cargando…

Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review

BACKGROUND: Ketamine is a novel rapid-acting antidepressant with high efficacy in treatment-resistant patients. Its exact therapeutic mechanisms of action are unclear; however, in recent years its anti-inflammatory properties and subsequent downstream effects on tryptophan (TRP) metabolism have spar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kopra, Emma, Mondelli, Valeria, Pariante, Carmine, Nikkheslat, Naghmeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358579/ https://www.ncbi.nlm.nih.gov/pubmed/34180293 http://dx.doi.org/10.1177/02698811211026426

Ejemplares similares

Inflammation in cancer and depression: a starring role for the kynurenine pathway
por: Sforzini, Luca, et al.
Publicado: (2019)

The interaction between kynurenine pathway, suicidal ideation and augmentation therapy with minocycline in patients with treatment-resistant depression
por: Nettis, Maria Antonietta, et al.
Publicado: (2023)

Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Nikkheslat, Naghmeh
Publicado: (2021)

Genetic Contributions of Inflammation to Depression
por: Barnes, Jacob, et al.
Publicado: (2017)

Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression
por: Hepgul, Nilay, et al.
Publicado: (2016)

The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
por: Kose, Melisa, et al.
Publicado: (2021)

The influence of comorbid depression and overweight status on peripheral inflammation and cortisol levels
por: McLaughlin, Anna P., et al.
Publicado: (2022)

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
por: Nettis, Maria Antonietta, et al.
Publicado: (2021)

Effects of inflammation on the kynurenine pathway in schizophrenia — a systematic review
por: Pedraz-Petrozzi, Bruno, et al.
Publicado: (2020)

A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation
por: Aas, Monica, et al.
Publicado: (2014)

Differential effect of interferon-alpha treatment on AEA and 2-AG levels
por: Zajkowska, Zuzanna, et al.
Publicado: (2020)

Childhood trauma, HPA axis activity and antidepressant response in patients with depression
por: Nikkheslat, Naghmeh, et al.
Publicado: (2020)

What can neuroimmunology teach us about the symptoms of long-COVID?
por: Mondelli, Valeria, et al.
Publicado: (2021)

Using quantitative MRI to study brain responses to immune challenge with interferon-α
por: Nettis, Maria Antonietta, et al.
Publicado: (2021)

Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): evidence from a systematic review with meta-analysis
por: Chang, Jane Pei-Chen, et al.
Publicado: (2021)

Exploring the role of immune pathways in the risk and development of depression in adolescence: Research protocol of the IDEA-FLAME study
por: Mondelli, Valeria, et al.
Publicado: (2021)

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)

Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients: CRP and IL-6 as sex-specific predictors of treatment response
por: Lombardo, Giulia, et al.
Publicado: (2022)

Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome
por: Russell, Alice, et al.
Publicado: (2019)

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
por: Phillips, Robert S., et al.
Publicado: (2019)

Treatment-resistant depression and peripheral C-reactive protein
por: Chamberlain, Samuel R., et al.
Publicado: (2019)

Maternal depression during pregnancy and offspring depression in adulthood: role of child maltreatment
por: Plant, Dominic T., et al.
Publicado: (2015)

HIV and Comorbidities – the importance of Gut Inflammation and the Kynurenine Pathway
por: MacCann, R, et al.
Publicado: (2023)

Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms
por: Vancassel, Sylvie, et al.
Publicado: (2018)

Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells
por: Horowitz, Mark Abie, et al.
Publicado: (2015)

The role of circulatory systemic environment in predicting interferon-alpha–induced depression: The neurogenic process as a potential mechanism
por: Borsini, Alessandra, et al.
Publicado: (2019)

The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
por: Almulla, Abbas F., et al.
Publicado: (2022)

Identifying the women at risk of antenatal anxiety and depression: A systematic review
por: Biaggi, Alessandra, et al.
Publicado: (2016)

Subcutaneous Ketamine in Depression: A Systematic Review
por: Cavenaghi, Vitor Breseghello, et al.
Publicado: (2021)

Ketamine for Bipolar Depression: A Systematic Review
por: Bahji, Anees, et al.
Publicado: (2021)

Ketamine for bipolar depression: an updated systematic review
por: Fancy, Farhan, et al.
Publicado: (2023)

Involvement of kynurenine pathway between inflammation and glutamate in the underlying etiopathology of CUMS-induced depression mouse model
por: Wu, Xingying, et al.
Publicado: (2022)

Antenatal depression programs cortisol stress reactivity in offspring through increased maternal inflammation and cortisol in pregnancy: The Psychiatry Research and Motherhood – Depression (PRAM-D) Study
por: Osborne, S., et al.
Publicado: (2018)

Changes of Altruistic Behavior and Kynurenine Pathway in Late-Life Depression
por: Wu, Yujie, et al.
Publicado: (2020)

Ketamine treatment for depression: qualitative study exploring patient views
por: Jilka, Sagar, et al.
Publicado: (2021)

Cause or consequence? Understanding the role of cortisol in the increased inflammation observed in depression
por: Amasi-Hartoonian, Nare, et al.
Publicado: (2022)

Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review
por: Sukhram, Shiryn D., et al.
Publicado: (2022)

Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study
por: Sforzini, Luca, et al.
Publicado: (2023)

Neurodevelopmental outcome for offspring of women treated for antenatal depression: a systematic review
por: Previti, Giovanni, et al.
Publicado: (2014)

Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways
por: Correia, Ana Salomé, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ltnu61f98kkkhup97p5fokmctv